Identification
Personal identification
- Full name
- Luís Carlos Oliveira Lima
Citation names
- Lima, Luís
Author identifiers
- Ciência ID
- 9F16-0E29-D9FC
- ORCID iD
- 0000-0001-8152-9237
- Scopus Author Id
- 23501978900
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Upper intermediate (B2) | Proficiency (C2) | Advanced (C1) | Upper intermediate (B2) | |
French | Beginner (A1) | Beginner (A1) | Beginner (A1) | Beginner (A1) |
Education
Degree | Classification | |
---|---|---|
2014
Concluded
|
Doutoramento em Ciências Biomédicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Factores Preditivos de Resposta à Terapêutica Intravesical com BCG" (THESIS/DISSERTATION)
|
Aprovado com distinção |
2008/01/08
Concluded
|
Mestrado em Medicina e Oncologia Molecular (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
"Apoptosis and Fas/FasL Pathway: Role of FAS and FASL Functional Polymorphisms in Prostate Cancer Development" (THESIS/DISSERTATION)
|
Muito Bom |
2005
Concluded
|
Licencuiatura em Biologia Aplicada (Licenciatura)
Universidade do Minho Escola de Ciências, Portugal
"Bladder Cancer" (THESIS/DISSERTATION)
|
15 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2024/08/01 - Current | Auxiliary Researcher (Research) | Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal |
2019/01/02 - 2024/07/31 | Contracted Researcher (Research) | Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2018/12/10 - 2019/09/10 | Invited Adjunct Teacher (Polytechnic Teacher) | Instituto Politécnico do Porto Escola Superior de Saúde, Portugal |
2009/09/14 - 2015/09/14 | Invited Assistant (Polytechnic Teacher) | Instituto Politécnico do Porto Escola Superior de Saúde, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2011/07/02 - Current | Researcher at Experimental Patology and Therapeutics Group | Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal |
2009/01/15 - 2014/03/21 | PhD student | Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
2006/06/01 - 2011/07/01 | Researcher at Molecular Oncology Group | Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal |
2006/01/02 - 2008/01/08 | Master student in Molecular Medicine and Oncology | Universidade do Porto Faculdade de Medicina, Portugal |
2004/07/01 - 2005/11/30 | Applied Biology graduation intership | Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2025/01 - 2029/12 | Unveiling Transcriptome Landscape to Enhance Colorectal Cancer Screening: An Integrated Approach
2024.04511.BD
Supervisor
|
|
2023/12/27 - 2027/12/26 | An Integrative Approach for Biomarker Discovery in Colorectal Cancer: From Screening to Therapeutics
CI-IPOP-776_6_BD
Supervisor
|
Ongoing
|
2023 - 2027 | Challenging invasive fungal infections: Development of innovative electrochemical nanogenosensors to detect Aspergillus spp,
Candida spp, and Zygomycetes
FCT 2023.05159.BDANA
Supervisor
|
Ongoing
|
2022/01/01 - 2025/12/31 | Introducing molecular analysis of Circulating Tumour Cells in the clinic: Their significance in clonal evolution and immune
escape in gastrointestinal cancers
2021.05593.BD
Supervisor
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2025/01 - 2025/12 | Enhancing Colorectal Cancer Screening through Machine Learning-Based Biomarker Identification
LPCCN
Supervisor
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Ongoing
|
2020/09/01 - 2023/08/31 | Glycan-based solutions for improving metastatic colorectal cancer patients’ management.
2020.09394.BD
Supervisor
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2021/01/01 - 2021/12/31 | The Role of Circulating Tumour Cells in Colorectal Cancer Liver Metastasis Management
LPCC-NRN 2022
Supervisor
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte
Concluded
|
2018/03 - 2018/12 | Circulating tumor cells in gastrointestinal cancers: role and development of tools to improve cancer management and individualized
testing of treatment susceptibility
SFRH/BPD/101827/2014
Post-doc Fellow
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2015/03 - 2018/03 | Exploring glycobiomarkers as targets for bladder cancer chemoresistant cells
SFRH/BPD/101827/2014
Post-doc Fellow
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2009/03 - 2013/03 | Predictive Factors of Response to Intravesical Therapy with BCG
SFRH/BD/43399/2008
PhD Student Fellow
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
Contract
Designation | Funders | |
---|---|---|
2023/01/01 - 2026/12/31 | ONCOSCREEN: A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening
methods and viable policy pathways
101097036
Co-Principal Investigator (Co-PI)
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
European Commission
Ongoing
|
2022/01/01 - 2024/12/01 | RESOLVE: Rational Design of Multivalent Glycocode-Inspired Nanovaccines for Gastric Cancer Immunotherapy
PTDC/MED-OUT/2512/2021
Researcher
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2023/02/01 - 2024/07/31 | BioFaeC: Novel faecal biomarkers for early detection of precancerous lesions and cancer - Improving the current model for
colorectal cancer screening
2022.09051.PTDC
Co-Principal Investigator (Co-PI)
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2019/01/01 - 2019/12/31 | Centro de Investigação do Instituto Português de Oncologia do Porto
UID/DTP/00776/2019
UID/DTP/04750/2019
UIDB/04750/2020
UIDB/00776/2020
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal Universidade do Porto Instituto de Saúde Pública, Portugal Universidade do Porto Unidade de Investigação em Epidemiologia, Portugal Universidade do Porto Faculdade de Medicina, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2019/01/01 - 2019/12/31 | Institute for Research and Innovation in Health Sciences
UID/BIM/04293/2019
LA/P/0070/2020
Instituto Nacional de Engenharia Biomédica, Portugal
Universidade do Porto, Portugal Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal |
Fundação para a Ciência e a Tecnologia
Concluded
|
2011/01/01 - 2013/12/31 | Projecto Estratégico - UI 776 - 2011-2012
PEst-OE/SAU/UI0776/2011
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
Other
Designation | Funders | |
---|---|---|
2020 - Current | IDEAR: Neoadjuvant Immunotherapy with Durvalumab (MEDI4736) in Non-Surgical Early Stage or Located Advanced Non-Small Cell
Lung Cancer (NSCLC) followed by Radical Radiotherapy or Chemotherapy (Phase II, single arm, clinical trial)¿.
PI-97
Researcher
|
Ongoing
|
2022/01/01 - 2025/12/31 | RISE: Health Research Network: From Lab to Community Health
LA/P/0053/2020
Researcher
Fundação para a Ciência e a Tecnologia, Portugal
|
Ongoing
|
2021 - 2023 | TeamUp4Cancer: Porto Comprehensive Cancer Center
NORTE-01-0145- FEDER-072678
Researcher
|
|
2017 - 2020 | ESTIMA: Early-stage cancer treatment, driven by context of molecular imaging
NORTE-01-0145-FEDER-000027
Researcher
European Regional Development Fund, Belgium
|
Concluded
|
2013 - 2015 | Identification of bladder cancer stem cell glycobiomarkers based on chemotherapy sorting approach
Bolsa de Investigação APU/PFIZER 2013
Researcher
Associação Portuguesa de Urologia, Portugal
|
Concluded
|
Outputs
Publications
Book chapter |
|
Conference abstract |
|
Conference paper |
|
Conference poster |
|
Journal article |
|
Preprint |
|
Intellectual property
Patent |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2024/05 | MicroRNA Profiles and their Clinical Value for Precancerous and Cancerous Colorectal Lesions Identification: A Preliminary Study | 30th Porto Cancer Meeting
(Porto, Portugal)
|
2023/11/09 | Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion. | 1st Young Researchers’ Day
(Porto, Portugal)
|
2023/10/25 | Building a sample-to-answer CTC technology: joint path of clinical translation. | P.CCC Raquel Seruca Immuno-Oncology Club
(Porto, Portugal)
|
2023/07 | Enhanced specificity of CTC identification using a double exclusion biomarker assay. |
VI Annual Meeting CINBIO (Vigo, Spain)
|
2023/06/02 | Exploring Circulating Tumor Cells: Advancements in Identification and their Implications for Oral Cancer. | II International Congress of UNIPRO Research Unit and II Conference in Advances in Research on Oral Cancer
(Penafiel, Portugal)
|
2023/05/12 | Hypoxia and glucose deprivation induce bladder cancer cells dormancy and immature glycosylation driving cancer aggressiveness. | 29th Porto Cancer Meeting
(Porto, Portugal)
|
2022/09/24 | Optimização de imunocitoquímica on-chip para caracterização de Células Tumorais Circulantes em cancro de mama, colorrectal e pulmão | 4º Encontro Nacional de Jovens Investigadores em Oncologia
(Porto, Portugal)
|
2022/02 | Label-free Microfluidic-based Isolation of Circulating Tumor Cells from Gastrointestinal Cancer Samples | PortASAP Final Meeting
(Tallin, Estonia)
|
2021 | Microfluidic-based Isolation of Gastrointestinal Circulating Tumour Cells | EuroNanoForum Conference
(Portugal)
|
2016 | Imunoterapia em Urologia Oncologica: Estado da arte | XXI Workshop de Urologia Oncológica
(Carvoeiro, Portugal)
|
2015 | A step towards personalized medicine: establishment of a pharmacogenomics profile of response to BCG intravesical immunotherapy in bladder cancer | II INTERNATIONAL HEALTH CONGRESS GAIA-PORTO (II CISGP)
(Porto)
|
2015 | Role of pharmacogenomics in predicting antidepressant response and individualizing therapy | II INTERNATIONAL HEALTH CONGRESS GAIA-PORTO
(Gaia, Portugal)
|
2013 | A link between humoral response and the CA19-9 test in gastroesophageal cancer | Encontros de Primavera de Oncologia
(Évora, Portugal)
|
2011 | O-Glicomic Signatures of Urinary Glycoporteins in Bladder Cancer | Glupor 9 - 9th International Meeting of the Portuguese Carbohydrate Chemistry Group/ 5th Iberian Carbohydrate Meeting
(Vila Real, Portugal)
|
2010 | Carcinoma Urotelial e Superficial da Bexiga, de Alto Risco (CUB): BCG de Manutenção Associa-se a Menor Taxa de Recidiva | XIII Jornadas de Oncologia Médica
(Porto)
|
2008 | "Apoptosis and Fas/FasL Pathway: Role of FASL Functional Polymorphism in Prostate Cancer Development | ISCO |
2008 | Apoptosis and Fas/FasL Pathway: Role of FASL Functional Polymorphism in Prostate Cancer Development | ISCO
(Amestradam, Netherlands)
|
2008 | Cyclin D1 and bladder cancer:CCND1 polymorphism in bladder carcinogenesis and BCG immunotherapy | ESMO
(Estocolmo, Sweden)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2023 - Current | An Integrative Approach for Biomarker Discovery in Colorectal Cancer: From Screening to Therapeutics
Supervisor of Daniela Santos
|
Patologia e Genética Molecular (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2023 - Current | Challenging invasive fungal infections: Development of innovative electrochemical nanogenosensors to detect Aspergillus spp,
Candida spp, and Zygomycetes
Co-supervisor of Michelle Castanheira
|
Universidade do Porto, Portugal
|
2022/01/01 - Current | Introducing molecular analysis of Circulating Tumour Cells in the clinic: Their significance in clonal evolution and immune
escape in gastrointestinal cancers
Supervisor of Adriana Carneiro
|
Ciências Biomédicas (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2021/10/01 - Current | Novel faecal biomarkers for early detection of precancerous lesions and Cancer: Improving the current model for colorectal
cancer screening
Supervisor of Beatriz Oliveira
|
Oncologia (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2025/01 - 2028/12 | Unveiling Transcriptome Landscape to Enhance Colorectal Cancer Screening: An Integrated Approach
Supervisor
|
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2024/09 - 2025/11 | Identification and validation of biomarkers for improvement the colorectal cancer screening
Supervisor
|
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
|
2024/04 - 2024/07 | Blood Biomarkers as a promising approach for Early Colorectal Cancer Screening
Supervisor
|
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
|
2023 - 2024 | Enhancing Colorectal Cancer Screening: Identifying Promising Biomarkers for Early Detection
Supervisor of Débora Pinto
|
Health Biochemistry (Master)
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
|
2022 - 2023/11/23 | Identification of Fecal Biomarkers for Early Detection of Pre- and Cancerous Colorectal Lesions
Supervisor of Daniela Santos
|
Pharmacy-Technology and Medicines and Health Products (Master)
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
|
2023 - 2023 | Assessment of Sialyl-Tn in Stool as a non-invasive Colorectal Cancer Biomarker
Supervisor of João Almeida
|
Biotecnologia Medicinal (Degree)
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
|
2017/09 - 2021/09 | Exploring cancer circulating tumor cells for improved esophageal cancer management and ex vivo models for individualized testing
of treatment susceptibility
Co-supervisor of Sofia Cotton
|
Ciências Biomédicas (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2019/09 - 2020/11/24 | Circulating Tumour Cells: Paving The Way Towards The Identification of Ephitelial and Mesenchymal Phenotypes in the Clinic
Supervisor of Adriana Carneiro
|
Biotecnologia Farmacêutica (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
|
2018/09 - 2019/09 | Improvement of metastatic gastric cancer management glyco-exploring circulating tumor cells
Supervisor of Dylan Ferreira
|
Medicina e Oncologia Molecular (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
2016/09 - 2017/09 | CD44-glycoprofilling: Establishing the molecular basis for target therapeutics in bladder cancer
Co-supervisor of Eliana Janine Soares
|
Bioquímica (Master)
Universidade de Aveiro, Portugal
|
2015/09 - 2016/11 | Glycoproteomics Characterization of Advanced Bladder Cancer Toward Novel Therapies
Supervisor of Sofia Cotton
|
Biologia Molecular e Celular (Master)
Universidade de Aveiro, Portugal
|
2013/09 - 2014/09 | Glyco-profiling of bladder cancer stem cells based on the chemotherapy sorting approach
Co-supervisor of Beatriz Parreira
|
Oncologia (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2012/05 - 2013/09 | Macrophages biomarkers in the BCG treatment response in Bladder Cancer
Co-supervisor of Daniela Oliveira
|
Bioquímica em Saúde (Master)
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2023/06/28 - Current | RUBYnanomed: Sessão Pública de Apresentação de Resultados do Projeto Bright (2023) | Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal |
2016 - Current | First Precision Oncology Pre-conference workshop on molecular methods in oncology (2016)
Conference
|
Universidade Fernando Pessoa, Portugal |
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2023/11 | The role of extracellular vesicles-derived microRNAs in the development of Renal Cell Carcinoma
(Thesis) Arguer
|
Patrícia Venâncio (Master)
Instituto Politécnico do Porto, Portugal
|
2023/09 | Research of Biomarkers for the Detection of Colorectal Cancer by Non-Invasive Methods
(Thesis) Arguer
|
Maria João Combo (Master)
Universidade de Coimbra, Portugal
|
Evaluation committee
Activity description Role |
Institution / Organization | Funding entity | |
---|---|---|---|
2024 - Current | Evaluator for the PATHFINDER CHALLENGE 2023: remoter evaluater, cross reader and evaluation panel member | ||
2015 - Current | Evaluator for the MATWIN programme: Maturation & accelerating translation of research projects in oncology with potential for industry |
Journal scientific committee
Journal title (ISSN) | Publisher | |
---|---|---|
2023 - Current | Guest Editor of International Journal of Molecular Sciences | |
2021 - 2022 | Guest Editor of International Journal of Molecular Sciences |